This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Novartis Ag. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Innovations of Hans Hirt in Pharmaceutical Chemistry
Introduction
Hans Hirt is a notable inventor based in Reinach, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of renin inhibitors and angiotensin II receptor antagonists. With a total of 2 patents, his work has had a considerable impact on the synthesis of important pharmaceutical compounds.
Latest Patents
One of Hans Hirt's latest patents is focused on a novel process for preparing renin inhibitors. This invention provides innovative process steps and intermediates that are essential in synthesizing pharmaceutically active compounds, especially renin inhibitors like Aliskiren. The process involves reacting a specific compound with a reagent that transforms hydroxy into a leaving group, facilitating the manufacture of the desired compound.
Another significant patent relates to coupling reactions useful in the preparation of (1H-tetrazol-5-yl) biphenyl derivatives. This invention outlines a process for manufacturing intermediates that can be used to create angiotensin II receptor antagonists, which share a common structural feature of a (1H-tetrazol-5-yl)-biphenyl ring.
Career Highlights
Hans Hirt is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative pharmaceutical research and development. His contributions have been instrumental in advancing the field of drug synthesis and improving therapeutic options for patients.
Collaborations
Throughout his career, Hans Hirt has collaborated with esteemed colleagues such as Stuart J Mickel and Gottfried Sedelmeier. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical processes.
Conclusion
Hans Hirt's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant inventor in the field. His innovative processes for synthesizing renin inhibitors and angiotensin II receptor antagonists continue to influence the development of effective therapeutic agents.